{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:12:42Z","timestamp":1791821562300,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-025-03522-7","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T06:11:46Z","timestamp":1751091106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of cilostazol for in-stent restenosis after carotid artery stenting: a meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Jing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"issue":"4","key":"3522_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.amjmed.2021.09.027","volume":"135","author":"S Hassani","year":"2022","unstructured":"Hassani S, Fisher M. Management of atherosclerotic carotid artery disease: A brief overview and update. Am J Med. 2022;135(4):430\u20134.","journal-title":"Am J Med"},{"issue":"3","key":"3522_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/NRL.0000000000000383","volume":"27","author":"X Cai","year":"2022","unstructured":"Cai X, Chen X, Xiang Y, et al. Balloon-assisted angioplasty for the treatment of in-stent restenosis after vertebral artery ostium stenting: experiences from one single center. Neurologist. 2022;27(3):106\u201310.","journal-title":"Neurologist"},{"issue":"7","key":"3522_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S1474-4422(18)30195-9","volume":"17","author":"LH Bonati","year":"2018","unstructured":"Bonati LH, Gregson J, Dobson J, McCabe DJH, Nederkoorn PJ, van der Worp HB, et al. Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the international carotid stenting study (ICSS): secondary analysis of a randomised trial. Lancet Neurol. 2018;17(7):587\u201396.","journal-title":"Lancet Neurol"},{"issue":"19","key":"3522_CR4","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.21037\/atm-20-963","volume":"8","author":"F Stilo","year":"2020","unstructured":"Stilo F, Montelione N, Calandrelli R, Distefano M, Spinelli F, Di Lazzaro V, Pilato F. The management of carotid restenosis: a comprehensive review. Ann Transl Med. 2020;8(19):1272.","journal-title":"Ann Transl Med"},{"issue":"10","key":"3522_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S1474-4422(08)70196-0","volume":"7","author":"HH Eckstein","year":"2008","unstructured":"Eckstein HH, Ringleb P, Allenberg JR, Berger J, Fraedrich G, Hacke W, et al. Results of the Stent-Protected angioplasty versus carotid endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008;7(10):893\u2013902.","journal-title":"Lancet Neurol"},{"issue":"2","key":"3522_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1024\/0301-1526\/a001114","volume":"53","author":"R Martini","year":"2024","unstructured":"Martini R, Ageno W, Amato C, Favaretto E, Porfidia A, Vison\u00e0 A. Cilostazol for peripheral arterial disease - a position paper from the Italian society for angiology and vascular medicine. Vasa. 2024;53(2):109\u201319.","journal-title":"Vasa"},{"issue":"3","key":"3522_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/STROKEAHA.119.023855","volume":"51","author":"BJ Kim","year":"2020","unstructured":"Kim BJ, Kwon SU, Park JH, Kim YJ, Hong KS, Wong LKS, et al. Cilostazol versus aspirin in ischemic stroke patients with High-Risk cerebral hemorrhage: subgroup analysis of the PICASSO trial. Stroke. 2020;51(3):931\u20137.","journal-title":"Stroke"},{"key":"3522_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ijs.12460","volume":"10","author":"JS Kim","year":"2015","unstructured":"Kim JS, Kwon SU, Uchiyama S. Cilostazol research in asia: can it be applied to European and American patients? Int J Stroke. 2015;10:1\u20139.","journal-title":"Int J Stroke"},{"issue":"16","key":"3522_CR9","doi-asserted-by":"publisher","first-page":"e013306","DOI":"10.1161\/JAHA.119.013306","volume":"8","author":"K Toyoda","year":"2019","unstructured":"Toyoda K, Inoue M, Koga M. Small but steady steps in stroke medicine in Japan. J Am Heart Assoc. 2019;8(16):e013306.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"3522_CR10","doi-asserted-by":"publisher","first-page":"105581","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105581","volume":"30","author":"MP Lin","year":"2021","unstructured":"Lin MP, Meschia JF, Gopal N, Barrett KM, Ross OA, Ertekin-Taner N, Brott TG. Cilostazol versus aspirin for secondary stroke prevention: systematic review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2021;30(3):105581.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"3522_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/1526602815619409","volume":"23","author":"G Galyfos","year":"2016","unstructured":"Galyfos G, Geropapas G, Sigala F, Aggeli K, Sianou A, Filis K. Meta-Analysis of studies evaluating the effect of cilostazol on major outcomes after carotid stenting. J Endovasc Ther. 2016;23(1):186\u201395.","journal-title":"J Endovasc Ther"},{"key":"3522_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"3522_CR13","unstructured":"Cochlane handbook for. systematic reviews of interventions Version 5.1.0 [updated March 2011]. 2011 [J\/OL] [http:\/\/handbook-5-1.cochrane.org\/. cochrane.org\/]"},{"key":"3522_CR14","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ (Clinical Res ed). 2011;343:d5928.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"7414","key":"3522_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"J Higgins","year":"2003","unstructured":"Higgins J, Thompson S, Deeks J. Measuring inconsistency in meta-analyses. BMJ (Clinical Res ed). 2003;327(7414):557\u201360.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"12","key":"3522_CR16","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1161\/STROKEAHA.124.047210","volume":"55","author":"H Yamagami","year":"2024","unstructured":"Yamagami H, Ozaki T, Ogasawara K, Nagata I, Matsumaru Y, Yoshimura S, et al. Randomized controlled trial of cilostazol addition for In-Stent restenosis after carotid artery stenting. Stroke. 2024;55(12):2776\u201385.","journal-title":"Stroke"},{"issue":"3","key":"3522_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2176\/nmc.53.163","volume":"53","author":"M Tsutsumi","year":"2013","unstructured":"Tsutsumi M, Aikawa H, Nii K, Etou H, Sakamoto K, Kureshima M, et al. Cilostazol reduces periprocedural hemodynamic depression in carotid artery stenting. Neurol Med Chir (Tokyo). 2013;53(3):163\u201370.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"9","key":"3522_CR18","first-page":"1798","volume":"42","author":"S Yang Demin","year":"2019","unstructured":"Yang Demin S, Shan J. Effect and safety of cilostazol combined with aspirin and clopidogrel on thrombosis after neurointervention in patients with carotid artery stenosis. Drug Evaluation Res. 2019;42(9):1798\u2013801.","journal-title":"Drug Evaluation Res"},{"issue":"2","key":"3522_CR19","first-page":"63","volume":"14","author":"S Jin Yongjian","year":"2009","unstructured":"Jin Yongjian S, Jidong L, Haisheng C, Sanchuan C, Guoqiang Z. Effectiveness of combination of cilostazol and aspirin in preventing thrombosis after interventional neuroradiology procedures. Chin J Minim Invasive Neurosurg. 2009;14(2):63\u20135.","journal-title":"Chin J Minim Invasive Neurosurg"},{"issue":"7","key":"3522_CR20","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3174\/ajnr.A2955","volume":"33","author":"T Kato","year":"2012","unstructured":"Kato T, Sakai H, Takagi T, Nishimura Y. Cilostazol prevents progression of asymptomatic carotid artery stenosis in patients with contralateral carotid artery stenting. AJNR Am J Neuroradiol. 2012;33(7):1262\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"3522_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.06.007","volume":"21","author":"H Yamagami","year":"2012","unstructured":"Yamagami H, Sakai N, Matsumaru Y, Sakai C, Kai Y, Sugiu K, et al. Periprocedural cilostazol treatment and restenosis after carotid artery stenting: the retrospective study of In-Stent restenosis after carotid artery stenting (ReSISteR-CAS). J Stroke Cerebrovasc Dis. 2012;21(3):193\u20139.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"3522_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1136\/neurintsurg-2014-011565","volume":"8","author":"Y Miyazaki","year":"2016","unstructured":"Miyazaki Y, Mori T, Iwata T, Aoyagi Y, Tanno Y, Kasakura S, Yoshioka K. Continuous daily use of cilostazol prevents in-stent restenosis following carotid artery stenting: serial angiographic investigation of 229 lesions. J Neurointerv Surg. 2016;8(5):471\u20135.","journal-title":"J Neurointerv Surg"},{"issue":"11","key":"3522_CR23","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3174\/ajnr.A3127","volume":"33","author":"K Takayama","year":"2012","unstructured":"Takayama K, Taoka T, Nakagawa H, Myouchin K, Wada T, Sakamoto M, et al. Effect of cilostazol in preventing restenosis after carotid artery stenting using the carotid wallstent: a multicenter retrospective study. AJNR Am J Neuroradiol. 2012;33(11):2167\u201370.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"3522_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jvs.2009.08.040","volume":"51","author":"T Takigawa","year":"2010","unstructured":"Takigawa T, Matsumaru Y, Hayakawa M, Nemoto S, Matsumura A. Cilostazol reduces restenosis after carotid artery stenting. J Vasc Surg. 2010;51(1):51\u20136.","journal-title":"J Vasc Surg"},{"issue":"4","key":"3522_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"3522_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE:an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"issue":"5","key":"3522_CR27","first-page":"439","volume":"65","author":"R El Khoury","year":"2024","unstructured":"El Khoury R, Asha A, Bystrom PV, Weiss R, Jacobs CE, Schwartz LB. In-stent restenosis. J Cardiovasc Surg (Torino). 2024;65(5):439\u201353.","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"3522_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.carrev.2021.01.007","volume":"24","author":"EJ Armstrong","year":"2021","unstructured":"Armstrong EJ, Kokkinidis DG. Restenosis after carotid artery stenting. Cardiovasc Revasc Med. 2021;24:70\u20131.","journal-title":"Cardiovasc Revasc Med"},{"issue":"4456","key":"3522_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1126\/science.6994228","volume":"209","author":"ID Goldberg","year":"1980","unstructured":"Goldberg ID, Stemerman MB, Handin RI. Vascular permeation of platelet factor 4 after endothelial injury. Science. 1980;209(4456):611\u20132.","journal-title":"Science"},{"key":"3522_CR30","doi-asserted-by":"publisher","first-page":"105683","DOI":"10.1016\/j.phrs.2021.105683","volume":"169","author":"X Cui","year":"2021","unstructured":"Cui X, Pan G, Chen Y, Guo X, Liu T, Zhang J, et al. The p53 pathway in vasculature revisited: A therapeutic target for pathological vascular remodeling? Pharmacol Res. 2021;169:105683.","journal-title":"Pharmacol Res"},{"issue":"4","key":"3522_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10557-021-07187-x","volume":"36","author":"RY Kherallah","year":"2022","unstructured":"Kherallah RY, Khawaja M, Olson M, Angiolillo D, Birnbaum Y. Cilostazol: a review of basic mechanisms and clinical uses. Cardiovasc Drugs Ther. 2022;36(4):777\u201392.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"3522_CR32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jvs.2011.07.087","volume":"55","author":"T Takigawa","year":"2012","unstructured":"Takigawa T, Tsurushima H, Suzuki K, Tsuruta W, Nakamura K, Matsumura A. Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of Sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cells. J Vasc Surg. 2012;55(2):506\u201316.","journal-title":"J Vasc Surg"},{"issue":"1","key":"3522_CR33","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.1038\/s41598-021-87339-z","volume":"11","author":"WX Wang","year":"2021","unstructured":"Wang WX, Wang T, Ma L, Sun ZH, Wang GS. New-onset lesions on MRI-DWI and cerebral blood flow changes on 3D-pCASL after carotid artery stenting. Sci Rep. 2021;11(1):8005.","journal-title":"Sci Rep"},{"key":"3522_CR34","doi-asserted-by":"publisher","first-page":"9084643","DOI":"10.1155\/2019\/9084643","volume":"2019","author":"S Konosic","year":"2019","unstructured":"Konosic S, Petricevic M, Ivancan V, Konosic L, Goluza E, Krtalic B, et al. Intragastric application of aspirin, clopidogrel, cilostazol, and BPC 157 in rats: platelet aggregation and blood clot. Oxid Med Cell Longev. 2019;2019:9084643.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"3522_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s11239-020-02214-4","volume":"51","author":"ML Guarino","year":"2021","unstructured":"Guarino ML, Massimi I, Alemanno L, Conti L, Angiolillo DJ, Pulcinelli FM. MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation. J Thromb Thrombolysis. 2021;51(3):625\u201332.","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"3522_CR36","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1160\/TH12-04-0232","volume":"108","author":"A Borgognone","year":"2012","unstructured":"Borgognone A, Pulcinelli FM. Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport. Thromb Haemost. 2012;108(5):955\u201362.","journal-title":"Thromb Haemost"},{"issue":"4","key":"3522_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/1526602818783505","volume":"25","author":"P Texakalidis","year":"2018","unstructured":"Texakalidis P, Giannopoulos S, Kokkinidis DG, Lanzino G. Effect of Open- vs Closed-Cell stent design on periprocedural outcomes and restenosis after carotid artery stenting: A systematic review and comprehensive Meta-analysis. J Endovasc Ther. 2018;25(4):523\u201333.","journal-title":"J Endovasc Ther"},{"key":"3522_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.carrev.2020.09.005","volume":"24","author":"M Megaly","year":"2021","unstructured":"Megaly M, Alani F, Cheng CI, Ragina N. Risk factors for the development of carotid artery In-Stent restenosis: multivariable analysis. Cardiovasc Revasc Med. 2021;24:65\u20139.","journal-title":"Cardiovasc Revasc Med"},{"key":"3522_CR39","doi-asserted-by":"publisher","first-page":"814654","DOI":"10.3389\/fneur.2022.814654","volume":"13","author":"E Chai","year":"2022","unstructured":"Chai E, Chen J, Li C, Zhang X, Fan Z, Yang S, et al. The efficacy and safety of cilostazol vs. Aspirin for secondary stroke prevention: A systematic review and Meta-Analysis. Front Neurol. 2022;13:814654.","journal-title":"Front Neurol"},{"issue":"4","key":"3522_CR40","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1161\/STROKEAHA.110.589309","volume":"42","author":"C Arquizan","year":"2011","unstructured":"Arquizan C, Trinquart L, Touboul PJ, Long A, Feasson S, Terriat B, et al. Restenosis is more frequent after carotid stenting than after endarterectomy: the EVA-3S study. Stroke. 2011;42(4):1015\u201320.","journal-title":"Stroke"},{"issue":"6","key":"3522_CR41","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(19)30148-6","volume":"18","author":"K Toyoda","year":"2019","unstructured":"Toyoda K, Uchiyama S, Yamaguchi T, Easton JD, Kimura K, Hoshino H, et al. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in japan: a multicentre, open-label, randomised controlled trial. Lancet Neurol. 2019;18(6):539\u201348.","journal-title":"Lancet Neurol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03522-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-025-03522-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03522-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T19:02:28Z","timestamp":1751137348000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-025-03522-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3522"],"URL":"https:\/\/doi.org\/10.1186\/s13019-025-03522-7","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript and the submission to this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}